biotech · Essential Tremor · Systemic Lupus Erythematosus
Chongqing Precision Biotech
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech is a biotech organization headquartered in Chongqing, CN. Primary therapeutic focus areas include Essential Tremor, Systemic Lupus Erythematosus, Focal Epilepsy, Multiple Myeloma, Colorectal C
重庆市创业大道高科创业园A栋, Chongqing, CN HQ
2016 Founded
5 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- 重庆市创业大道高科创业园A栋, Chongqing, CN
- Founded
- 2016
- Employees
- 5
- Programs
- 109
- Drugs
- 57
- Patents
- 158
CEA-targeted CAR-T (Intravenous)
Phase 1 · mab · NSCLC (Advanced Non-small Cell Lung Cancer)
CEA-targeted CAR-T (Intravenous) for NSCLC (Advanced Non-small Cell Lung Cancer) is a Phase 1 program (mab) at Chongqing Precision Biotech Co., Ltd with 1 ClinicalTrials.gov record(s).
Internal code 2025-0883
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Chongqing Precision Biotech Co., Ltd
- Phase
- Phase 1
- Modality
- mab
- Indication
- NSCLC (Advanced Non-small Cell Lung Cancer)
- Status
- active
- Trials
- 1